NovaBridge Biosciences.

Research NovaBridge Biosciences. (NBP) on Bullrun: market cap USD 228.98M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNBP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 228.98M
• Financial periodFY2025
• Net income-USD 46.27M
• Free cash flow-USD 20.60M

Valuation Snapshot

latest market cap is USD 228.98M.

About NovaBridge Biosciences.

NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology. Its product pipeline comprises givastomig, a potential CLDN18.2 bispecific antibody, which is in phase 2 clinical trial combination with nivolumab and chemotherapy for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies;

Frequently asked questions

What is NovaBridge Biosciences.'s market cap?

NovaBridge Biosciences.'s market capitalization is USD 228.98M.

What does NovaBridge Biosciences. do?

NovaBridge Biosciences, a biotechnology company, engages in the research and development of immuno-oncology agents for the treatment of cancer in the United States. The company operates through two segments, Oncology and Ophthalmology.